Trials / Conditions / Gastrointestinal Neuroendocrine Tumors
Gastrointestinal Neuroendocrine Tumors
5 registered clinical trials studyying Gastrointestinal Neuroendocrine Tumors — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrin NCT06479811 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal NCT06427798 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients NCT05411133 | Arbele Pty Ltd | Phase 1 |
| Recruiting | Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases NCT02185443 | University of Sao Paulo | Phase 2 |
| Terminated | Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors NCT01648465 | Hellenic Cooperative Oncology Group | Phase 2 |